Developing an ‘on and off’ Switch for Breast Cancer Treatment

T-cells play an important role in the body’s immune system, and one of their tasks is to find and destroy infection. However, T-cells struggle to identify solid, cancerous tumors in the body. A current cancer therapy is using these T-cells and genetically engineering them to kill cancer, but these cells, known as CAR-T cells, have been known to attack off-target sites while completing their job. In order to counteract this negative effect, University of Notre Dame researchers are working to create nanoparticles that act as an “on and off” switch to improve the safety and effectiveness of this cancer therapy.

Read more here.

August 17, 2018

Health and SocietyScience and TechnologyAerospace and Mechanical EngineeringCenter for Nano Science and Technology (NDnano)Chemistry and BiochemistryCollege of EngineeringCollege of ScienceHarper Cancer Research InstituteLance HellmanMedicinePaul HelquistPrakash NallathambyResearch

More Like This

Related Posts

Let your curiosity roam! If you enjoyed the insights here, we think you might enjoy discovering the following publications.

Stay In Touch

Subscribe to our Newsletter

To receive the latest and featured content published to ThinkND, please provide your name and email. Free and open to all.

What interests you?
Select your topics, and we'll curate relevant updates for your inbox.